- ►shouxi.net M Schupp, M Clemenz, R Gineste, H Witt, J … - Diabetes, 2005 - Am Diabetes Assoc Selective peroxisome proliferator–activated receptor (PPAR) γ modulation is a
new pharmacological approach that, based on selective receptor-cofactor
interactions and target gene regulation, should result in potent insulin ... Cited by 141 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org [PDF] Y Miura, N Yamamoto, S Tsunekawa, S Taguchi … - Diabetes Care, 2005 - Am Diabetes Assoc Cardiac ventricles release B-type na- triuretic peptide (BNP) in response to
volume expansion and pressure overload; therefore, BNP concentration may be used
as a biochemical marker of cardiac failure (1). BNP levels are high in ... Cited by 59 - Related articles - All 5 versions
- ►ahajournals.org SC Benson, HA Pershadsingh, CI Ho, A … - Hypertension, 2004 - Am Heart Assoc The metabolic syndrome is a common precursor of cardiovascular disease and type
2 diabetes that is characterized by the clustering of insulin resistance,
dyslipidemia, and increased blood pressure. In humans, mutations in the ... Cited by 428 - Related articles - BL Direct - All 10 versions
- ►endojournals.org JP Berger, AE Petro, KL Macnaul, LJ Kelly, … - Molecular Endocrinology, 2003 - Endocrine Soc Antidiabetic thiazolidinediones (TZDs) and non-TZD compounds have been shown to
serve as agonists of the peroxisome proliferator-activated receptor (PPAR ).
Here, we report the identification and characterization of a novel non-TZD ... Cited by 170 - Related articles - BL Direct - All 4 versions
K Sugimoto, NR Qi, L Kazdova, M Pravenec, T … - Hypertension, 2006 - Am Heart Assoc From the Department of Laboratory Medicine (KS, NRQ, TWK), University of
California, San Francisco; Department of Geriatric Medicine (KS, TO), Osaka
University Graduate School of Medicine, Osaka, Japan; Institute for ... Cited by 74 - Related articles - All 6 versions
- ►ahajournals.org M Schupp, J Janke, R Clasen, T Unger, U … - Circulation, 2004 - Am Heart Assoc Methods and Results— The ARBs irbesartan and telmisartan (10 µmol/L) potently
enhanced PPAR -dependent 3T3-L1 adipocyte differentiation associated with a
significant increase in mRNA expression of the adipogenic marker gene ... Cited by 435 - Related articles - BL Direct - All 7 versions
C Vitale, G Mercuro, C Castiglioni, A Cornoldi, … - Cardiovascular Diabetology, 2005 - cardiab.com Metabolic syndrome is a cluster of common cardiovascular risk factors that
includes hypertension and insulin resistance. Hypertension and diabetes mellitus
are frequent comorbidities and, like metabolic syndrome, increase the risk ... Cited by 87 - Related articles - Cached - All 12 versions
G Derosa, PD Ragonesi, A Mugellini, L … - Hypertension Research, 2004 - 万方数据资源系统 We evaluated the antihypertensive activity, glucose homeostasis and plasma lipid
profile in patients with mild hypertension and type 2 diabetes mellitus treated
by diet and exercise, and not in receipt of oral hyperglycemics, following ... Cited by 87 - Related articles - BL Direct - All 4 versions
- ►ahajournals.org R Clasen, M Schupp, A Foryst-Ludwig, C … - Hypertension, 2005 - Am Heart Assoc The adipose-specific protein adiponectin has been recently discovered to improve
insulin sensitivity. Angiotensin type-1 receptor (AT1R) blockers (ARBs) reduce
the incidence of type 2 diabetes mellitus by mostly unknown molecular ... Cited by 127 - Related articles - All 9 versions
- ►aspetjournals.org T Fujimura, C Kimura, T Oe, Y Takata, H … - Journal of Pharmacology and Experimental …, 2006 - ASPET Adipogenesis is an important process for the improvement of insulin resistance
by peroxisome proliferator-activated receptor (PPAR) agonists, such as
rosiglitazone and pioglitazone. FK614 [3-(2,4-dichlorobenzyl)-2-methyl-N-( ... Cited by 30 - Related articles - BL Direct - All 5 versions
